This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Dec;74(6):e139-e140.

doi: 10.1016/j.eururo.2018.07.004. Epub 2018 Jul 18.

Re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database Consortium

Jeffrey Graham¹, Omar Abdel-Rahman¹, Toni K Choueiri², Daniel Y C Heng³; International mRCC Database Consortium

Affiliations

Affiliations

¹ Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.
² Dana Farber Cancer Institute, Harvard School of Medicine, Boston, MA, USA.
³ Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: daniel.heng@ahs.ca.

PMID: 30031571
DOI: 10.1016/j.eururo.2018.07.004

Comment

Re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database Consortium

Jeffrey Graham et al. Eur Urol. 2018 Dec.

. 2018 Dec;74(6):e139-e140.

doi: 10.1016/j.eururo.2018.07.004. Epub 2018 Jul 18.

Authors

Jeffrey Graham¹, Omar Abdel-Rahman¹, Toni K Choueiri², Daniel Y C Heng³; International mRCC Database Consortium

Affiliations

¹ Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.
² Dana Farber Cancer Institute, Harvard School of Medicine, Boston, MA, USA.
³ Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: daniel.heng@ahs.ca.

PMID: 30031571
DOI: 10.1016/j.eururo.2018.07.004

No abstract available

PubMed Disclaimer

Comment in

Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel Y.C. Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database Consortium.
Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber R, Goldhirsch A. Conforti F, et al. Eur Urol. 2019 Feb;75(2):e34-e35. doi: 10.1016/j.eururo.2018.08.034. Epub 2018 Sep 14. Eur Urol. 2019. PMID: 30224196 No abstract available.

Comment on

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber RD, Goldhirsch A. Conforti F, et al. Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16. Lancet Oncol. 2018. PMID: 29778737

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information